Invenomic Capital Management »

Xeris Pharmaceuticals shares owned by Invenomic Capital Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Invenomic Capital Management from 13F filings

Historical chart of Invenomic Capital Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Invenomic Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Invenomic Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 569k 2.35

More positions owned by Invenomic Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Us Home Cons Etf Put Option (ITB)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Viatris (VTRS)
Ss&c Technologies Holding (SSNC)
Illumina (ILMN)
Clarivate Ord Shs (CLVT)
Chord Energy Corporation Com New (CHRD)
Solaredge Technologies (SEDG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Zoom Video Communications In Cl A (ZM)
At&t (T)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Wright Express (WEX)
Quidel Corp (QDEL)

View all positions for Invenomic Capital Management

Top funds holding Xeris Pharmaceuticals

Vanguard Group
Rosalind Advisors
Millennium Management
D. E. Shaw & Co
Redmile Group
Citadel Advisors
Invenomic Capital Management
Tudor Investment Corporation
Lazard Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Jpmorgan Chase & Co
Barclays
AQR Capital Management
Alpine Partners VI

View all funds holding Xeris Pharmaceuticals